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Abstract
Introduction: The use of extracorporeal membrane oxygenation (ECMO) is considered a risk factor for, or even a potential con-
traindication to, lung transplantation. However, only a few pediatric cases have been described thus far.
Case Presentation: A 9-year-old boy with idiopathic pulmonary arterial hypertension developed cardiac arrest after the insertion
of a central catheter. ECMO was used as a bridge to lung transplantation. However, after prolonged resuscitation, he developed
medullary ischemia and medullary syndrome. After 6 weeks of ECMO and triple combination therapy for pulmonary hypertension,
including continuous intravenous prostacyclin, he was weaned off support, and after 2 weeks, bilateral lung transplantation was
performed. At 4 years post-transplant, he has minimal problems. The medullary syndrome has also alleviated. He is now back to
school and can walk with aids.
Conclusions: Increasing evidence supports the use of ECMO as a bridge to LT, reporting good outcomes. In the modern era of
PAH therapy, it is feasible to use prolonged ECMO support as a bridge to lung transplant, with the aim of weaning off this support;
however, its use requires more experience and knowledge of long-term outcomes.
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1. Introduction
The use of extracorporeal membrane oxygenation
(ECMO) has, for a long time, been considered a risk factor
for, or even a potential contraindication to, lung transplan-
tation (LT). Although, recent progress has challenged this
paradigm, controversy exists. The information of risks as-
sociated with ECMO is based on reports of individual case
reports or small case series (1), but two large series pub-
lished recently have reported ECMO as a feasible bridge to
LT and with acceptable outcomes (2, 3). However, only a few
pediatric cases have been reported thus far. Kirshbom et
al. reported that long-term outcome is comparable to pa-
tients not being on assist devices after support with ECMO
(4). Another report states that those children who can be
weaned off ECMO support before LT may have an even bet-
ter chance of survival (5).
2. Case Presentation
We present the case of a 9-year-old boy who received
prolonged ECMO support after suffering cardiac arrest and
eventually underwent double LT successfully. The patient
was diagnosed with idiopathic pulmonary arterial hyper-
tension (PAH) at 4 years of age and was considered a non-
responder to vasoreactivity testing. He had initially re-
ceived sildenafil as part of a randomized controlled trial,
with some beneficial effects. However, the family relo-
cated. He was brought to our clinic at 7 years of age.
Because of progression of symptoms (fatigue, dyspnea)
and an unsatisfactory hemodynamic profile, bosentan was
added to his therapy. After an initial improvement in re-
sponse to the combination therapy, the child showed con-
tinuous deterioration. Echocardiography showed severe
right ventricular (RV) dysfunction with massively dilated
RV compressing the left ventricle. Prostacyclin treatment
was suggested to the family, who preferred intravenous to
subcutaneous prostacyclin administration.
A Broviac® catheter was inserted to facilitate continu-
ous prostacyclin infusion. Although we recommended in-
sertion under local anesthesia, the family opted for gen-
eral anesthesia (GA), even after receiving an explanation of
the risks associated with GA. GA was administered using a
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mix of ketamine, etomidate, and midazolam for induction,
along with sevoflurane and fentanyl for maintenance. Car-
diac catheterization performed simultaneously showed a
pulmonary arterial pressure of 170/126 mmHg (mean 140
mmHg), a systemic arterial pressure of 98/62 mmHg (mean
74 mmHg), right atrial pressure of 26 mmHg, and cardiac
index of 1.8 L/min/×m2.
A permanent catheter was inserted; the procedure was
uneventful with stable hemodynamics. However, follow-
ing extubation in the operating room, the child developed
laryngospasm followed by a severe pulmonary hyperten-
sive crisis that led to cardiac arrest, unresponsive to max-
imal cardiopulmonary resuscitation (CPR), including the
use of inhaled nitric oxide.
Arterial blood gas analysis showed severe acidosis with
pH 6.9, PCO2 5kPa, HCO3 6.9 mmol, BE -24.6 mmol/L, and
lactate 15 mmol/L. Decision was taken to start ECMO. After
femoral veno-arterial cannulation with retrograde perfu-
sion of the femoral artery, ECMO was started 60 minutes
after CPR had been initiated. Abdominal compression and
head cooling were used during CPR to ensure brain oxy-
genation. Immediately after the initiation of ECMO, spon-
taneous cardiac activity was restored.
ECMO was first initiated as a bridge to LT. An atriosep-
tostomy was performed and intravenous prostacyclin was
started to allow for potential weaning from the support
when possible.
The patient developed several complications related
to prolonged CPR: transient acute renal failure; left an-
terior leg compartment syndrome requiring emergency
fasciotomy; and an unresolving anterior medullary syn-
drome at the level of L4 - L5 immediately after medullary
ischemia, without evidence of brain damage on cerebral
computed tomography. Spinal magnetic resonance imag-
ing was not possible as the patient was on ECMO. After
2 days of CPR, the child was kept on mild sedation; he
showed normal brain function but developed complete
paraplegia. Evoked potentials of the lower limbs were ab-
sent, consistent with anterior medullary ischemia at the
thoracic or lumbar level. Five days after the event, he
showed absence of abdominal cutaneous and lower limb
reflexes along with flask paraplegia. Proprioception was
preserved. This sensori-motor dissociation was in favor of
an anterior spinal cord ischemia.
After a long discussion with the transplant team and
the ethics committee, and because of the strong desire of
the family to pursue LT despite the peripheral neurologi-
cal damage, he was transferred to the national LT center
on ECMO. After 5 weeks of the triple combination ther-
apy including sildenafil, bosentan, and prostacyclin, he
could be weaned off ECMO. He developed recurrent lung
atelectasis, secondary to bronchial compression by the di-
lated pulmonary arteries that prevented extubation. A tra-
cheostomy was therefore performed only 6 weeks after
several unsuccessful attempts of extubation. He under-
went successful LT 12 weeks after the event. Prophylactic
ECMO support was used for 48 hours and thereafter was
weaned off without starting any cardiotonic support. Ven-
tilation was completely weaned off 25 days after LT. He was
discharged 61 days post-LT to a secondary care hospital,
which was close to his home, where a re-education pro-
gram was initiated. Echocardiography showed progressive
and rapid recovery of RV function.
At 4 years post-transplant, he has minimal problems.
His medullary syndrome has partially alleviated, but the
bladder dysfunction exists. He is back to school and can
walk with aids!
3. Discussion
This case is of interest for several reasons:
Prolonged ECMO support is feasible as a bridge to LT
in children with end-stage cardiopulmonary disease, and
even for idiopathic PAH. Recent evidence supports the use
of this strategy, reporting good long-term outcome (1-3, 5-
7). This case also illustrates that ECMO support may be
weaned off with aggressive PAH therapy, including triple
combination therapy and atrioseptostomy. Septostomy
was performed as an emergency procedure and the com-
munication was not sized. Sizing is indeed difficult, and
relevant data in pediatrics are not available. Another pos-
sible approach would be to perform a Potts shunt for de-
compressing the RV, but because of scarce data available
at the time of managing this case (no reports of patients
on ECMO) (8), the procedure was considered high risk with
the patient on ECMO. A current publication, nevertheless,
suggests (9) that this approach merits consideration and
further studies are required.
Recently, Sitbon et al. have shown dramatic improve-
ment with the triple combination therapy in severe PAH
(10). A similar approach may be used for aggressively de-
creasing the RV afterload in patients after cardiac arrest,
aiming to wean off ECMO if the patient is not receiving
complete treatment for PAH. In the past few years, we have
successfully used this approach in postoperative PAH af-
ter repair of congenital heart disease. The possibility of
ECMO weaning may increase the potential success of LT,
as reported by several groups (2, 5). ECMO can be used in
conscious adults and children. In pediatric patients, ECMO
requires the collaboration and an extremely good interac-
tion with the patient, as was the case with our patient. This
may not be always possible and would depend on the age
and ability of the patient to collaborate. This strategy is
of interest if prolonged circulatory support is necessary
2 Res Cardiovasc Med. 2016; 5(3):e32545.
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(6, 11). Finally, in our patient, double LT was performed
despite a post-CPR medullary syndrome, The decision to
transplant a patient with potential paraplegia remains a
difficult decision and should be taken on case-by-case ba-
sis (12). Such a decision is indeed difficult and is taken on a
case-by-case basis.
Our patient was treated several years ago with sequen-
tial oral combination therapy, which was initiated because
of continuous deterioration. A more aggressive approach
is supported by current adult and pediatric data, but was
not considered routine a few years ago. It must be remem-
bered that at the time of treating our patient, no pediatric
treatment had been approved for PAH, and therefore we
used the sequential combination reported for adults (13).
Another learning from this case is that intravenous
prostacyclin should probably be initiated before the inser-
tion of the central catheter. Even though no controlled
data are currently published to support this approach, we
strongly suggest that patients with severe PAH (functional
class 4) should first be stabilized using the triple combi-
nation therapy before GA or cardiac catheterization. Close
surveillance after the procedure is another critical element
in either intensive care or step-down units. GA has been re-
ported to be a potential risk factor in pediatric PAH (14).
Our group has previously described the possible use of
hypnosis to insert the central line in this setting, but this
was not an option available for our pediatric case (15).
ECMO support must be available in pediatric centers
that manage patients requiring invasive procedures such
as central catheter insertion or cardiac catheterization, i.e.
procedures often performed under GA. ECMO may offer
support to the patients as a bridge to LT when needed.
Another important learning is the high probability of
recovery of severely impaired RV function in the setting
of PAH once RV afterload is normalized. This has been
already described in LT, and it allows for double LT and
not heart-lung transplantation, but after pulmonary en-
darterectomy (16).
Increasing reports support the use of ECMO as a bridge
to LT, with good post-transplant outcomes. In the modern
era of PAH therapy, it is feasible to use prolonged ECMO as
a bridge to LT in pediatric patients who suffer cardiac ar-
rest, with the aim of weaning this support. However, it re-
quires substantial experience and long-term results to sup-
port the treatment successfully offered to this single pa-
tient.
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